{
  "kind": "treatment",
  "slug": "fluphenazine-decanoate-prolixin-decanoate",
  "type": "antipsychotic",
  "name": "Fluphenazine Decanoate (Prolixin Decanoate)",
  "summary": "A long-acting injectable typical antipsychotic used in the maintenance treatment of schizophrenia and other psychotic disorders.",
  "description": "Fluphenazine decanoate is the long-acting injectable ester form of the high-potency typical antipsychotic fluphenazine. It is administered intramuscularly every 2–4 weeks for maintenance therapy in patients with schizophrenia or chronic psychotic disorders. This depot formulation improves adherence and ensures sustained therapeutic drug levels.",
  "category": "medications/antipsychotics",
  "tags": [
    "typical-antipsychotic",
    "long-acting-injectable",
    "phenothiazine",
    "schizophrenia"
  ],
  "metadata": {
    "drug_classes": [
      "Phenothiazine",
      "Typical Antipsychotic"
    ],
    "therapeutic_categories": [
      "Psychosis",
      "Schizophrenia"
    ],
    "mechanism_categories": [
      "Dopamine Blocker"
    ],
    "administration_routes": [
      "Injection"
    ],
    "prescription_status": "Prescription Required",
    "controlled_substance": false,
    "generic_available": true,
    "brand_names": [
      "Prolixin Decanoate"
    ],
    "dea_schedule": null,
    "fda_pregnancy_category": "C",
    "age_groups": [
      "Adult",
      "Geriatric"
    ],
    "treatment_duration": [
      "Long-term"
    ],
    "specialty_areas": [
      "Psychiatry"
    ],
    "fda_approval_year": 1973
  },
  "clinical_metadata": {
    "primary_indications": [
      "Psychosis",
      "Other"
    ],
    "off_label_uses": [
      "Bipolar disorder (maintenance)"
    ],
    "contraindications": [
      "Hypersensitivity to fluphenazine or phenothiazines",
      "Coma",
      "CNS depression",
      "Severe liver disease"
    ],
    "monitoring_required": [
      "Extrapyramidal symptoms",
      "Tardive dyskinesia",
      "Prolactin levels",
      "ECG in cardiac risk"
    ],
    "efficacy_rating": {
      "psychosis": 4,
      "overall_tolerability": 3
    }
  },
  "search_metadata": {
    "searchable_terms": [
      "fluphenazine decanoate",
      "prolixin decanoate",
      "long-acting injectable",
      "phenothiazine",
      "typical antipsychotic"
    ],
    "synonyms": [
      "fluphenazine ester",
      "fluphenazine depot"
    ],
    "common_misspellings": [
      "flufenazine",
      "prolixan"
    ]
  },
  "sections": [
    {
      "type": "indications",
      "items": [
        "Schizophrenia",
        "Other chronic psychotic disorders"
      ]
    },
    {
      "type": "mechanism",
      "text": "Blocks postsynaptic dopamine D2 receptors in the mesolimbic pathway, reducing positive symptoms of psychosis; also antagonizes alpha-adrenergic and histamine receptors."
    },
    {
      "type": "dosing",
      "adult": {
        "start": "12.5–25 mg IM every 2 weeks",
        "titrate": "Adjust in increments of 12.5 mg based on response",
        "usual_range": "12.5–50 mg every 2–4 weeks",
        "max": "100 mg every 2 weeks"
      },
      "geriatric": "Use lower initial doses; monitor closely for EPS",
      "hepatic_impairment": "Use with caution; dose reduction may be required",
      "renal_impairment": "No specific adjustment; monitor closely"
    },
    {
      "type": "dosage_forms",
      "items": [
        "Injection (IM oil solution): 25 mg/mL"
      ]
    },
    {
      "type": "onset_duration",
      "text": "Onset within 48–96 hours; duration of action typically 2–4 weeks."
    },
    {
      "type": "adverse_effects",
      "common": [
        "extrapyramidal symptoms",
        "akathisia",
        "drowsiness",
        "blurred vision",
        "dry mouth",
        "constipation"
      ],
      "less_common": [
        "orthostatic hypotension",
        "hyperprolactinemia",
        "sexual dysfunction"
      ],
      "serious": [
        "tardive dyskinesia",
        "neuroleptic malignant syndrome",
        "QT prolongation"
      ]
    },
    {
      "type": "warnings",
      "black_box": "Increased mortality in elderly patients with dementia-related psychosis.",
      "other": [
        "Risk of EPS is higher with high-potency typical antipsychotics",
        "Monitor for tardive dyskinesia with long-term use",
        "Use with caution in cardiovascular disease"
      ]
    },
    {
      "type": "interactions",
      "items": [
        {
          "with": "CNS depressants",
          "risk": "Additive sedation",
          "action": "Use caution"
        },
        {
          "with": "Levodopa",
          "risk": "Reduced antiparkinsonian effect",
          "action": "Avoid combination"
        },
        {
          "with": "QT-prolonging drugs",
          "risk": "Increased risk of arrhythmia",
          "action": "Avoid or monitor ECG"
        }
      ]
    },
    {
      "type": "monitoring",
      "items": [
        "Extrapyramidal symptoms and tardive dyskinesia",
        "Weight, glucose, and lipids",
        "ECG if at risk for QT prolongation"
      ]
    },
    {
      "type": "special_populations",
      "pregnancy": "Use only if benefits outweigh risks",
      "lactation": "Excreted in breast milk; use caution",
      "pediatrics": "Not recommended",
      "geriatrics": "Increased sensitivity to EPS and anticholinergic effects"
    },
    {
      "type": "tapering",
      "text": "Gradual discontinuation recommended; monitor for relapse."
    },
    {
      "type": "clinical_notes",
      "items": [
        "Depot formulation is used for maintenance after establishing oral fluphenazine tolerability",
        "Higher potency means more EPS risk compared to low-potency agents"
      ]
    },
    {
      "type": "references",
      "items": [
        {
          "label": "Prolixin Decanoate Prescribing Information",
          "url": "https://www.accessdata.fda.gov/"
        },
        {
          "label": "Maudsley Prescribing Guidelines",
          "url": "https://www.wiley.com/"
        }
      ]
    }
  ],
  "seo": {
    "title": "Fluphenazine Decanoate (Prolixin Decanoate): Long-Acting Antipsychotic Dosing & Side Effects",
    "description": "Fluphenazine Decanoate is a high-potency typical antipsychotic depot injection used for maintenance treatment of schizophrenia."
  }
}
